Medifast (MED) Tops Q2 EPS by 55c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.44 -0.35%
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income from operations: 8.95M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q2 EPS of $0.92, $0.55 better than the analyst estimate of $0.37. Revenue for the quarter came in at $168.6 million versus the consensus estimate of $163.7 million.
GUIDANCE:
Medifast sees Q3 2024 EPS of $0.05-$0.07, versus the consensus of ($0.53). Medifast sees Q3 2024 revenue of $125-145 million, versus the consensus of $161.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
